Glucagon-like peptide-2

GCG
Identifiers
AliasesGCG, GLP1, glucagon, GRPP, GLP-1, GLP2
External IDsOMIM: 138030; MGI: 95674; GeneCards: GCG
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_002054

NM_008100

RefSeq (protein)

NP_002045

NP_032126

Location (UCSC)Chr 2: 162.14 – 162.15 MbChr 2: 62.3 – 62.31 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Glucagon-like peptide-2 (GLP-2) is a peptide hormone that in humans is encoded by the gene GCG. More precisely, proglucagon is produced from GCG, which can be cut by enzymes to produce a number of active hormones such as glucagon, GLP-1, or GLP-2, depending on the tissue. GLP-2 (and GLP-1) in particular are produced and secreted by the intestines with the help of the enzyme PCSK1. GLP-2 then signals to the intestines, inducing intestinal growth and increasing the height of intestinal villi.

GLP-2 is produced by the intestinal endocrine L cell and by various neurons in the central nervous system. Intestinal GLP-2 is co-secreted along with GLP-1 upon nutrient ingestion.

When externally administered, GLP-2 produces a number of effects in humans and rodents, including intestinal growth, enhancement of intestinal function, reduction in bone breakdown and neuroprotection. GLP-2 may act in an endocrine fashion to link intestinal growth and metabolism with nutrient intake. GLP-2 and related analogs (such as Teduglutide) may be treatments for short bowel syndrome, Crohn's disease, osteoporosis and as adjuvant therapy during cancer chemotherapy.

GLP-2 has an antidepressant effect in a mouse model of depression when delivered via intracerebroventricular injection. However, a GLP-2 derivative (PAS-CPP-GLP-2) was shown to be efficiently delivered to the brain intranasally, with similar efficacy.

Sequence

GLP-2 is a 33 amino acid peptide with sequence HADGSFSDEMNTILDNLAARDFINWLIQTKITD in humans (see Proteinogenic amino acid).

See also

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000115263 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000000394 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 3 4 "Pro-glucagon". UniProt. UniProt consortium. Retrieved 2026-10-24.
  6. ↑ Akita T, Kimura R, Akaguma S, Nagai M, Nakao Y, Tsugane M, et al. (July 2021). "Usefulness of cell-penetrating peptides and penetration accelerating sequence for nose-to-brain delivery of glucagon-like peptide-2". Journal of Controlled Release. 335: 575–583. doi:10.1016/j.jconrel.2021.06.007. PMID 34116136. S2CID 235412910.